Is Chronic Spontaneous Urticaria an Autoimmune Disease? What to Know About Thyroid Conditions and Treatment

TL;DR

• CSU can involve autoimmune mechanisms, but not every case can currently be classified as autoimmune. The 2026 international guideline recognizes type I autoimmune, or "autoallergic," CSU and type IIb autoimmune CSU, while some cases still have no identified underlying mechanism.
• Thyroid autoimmunity is more common in people with chronic urticaria than in people without it. A meta-analysis found people with chronic urticaria were more than five times as likely to have anti-thyroid peroxidase (anti-TPO) antibodies.
• In mama health's conversations with Italian CSU patients, a recorded thyroid condition came up in a small minority — far less often than it appears in studies that screen every participant's blood for thyroid antibodies. That gap reflects a real difference in what's being measured, not a contradiction.\[1\]
• Treating hypothyroidism or autoimmune thyroid disease is important for thyroid health, but normalising thyroid function does not reliably make CSU disappear. Current evidence on levothyroxine improving urticaria is conflicting.
• Negative allergy tests do not prove that CSU is autoimmune. They can help show that a specific external allergen has not been identified, while autoimmune testing and clinical assessment address a different question.
• Having autoimmune markers usually does not replace the standard CSU treatment pathway. Treatment remains focused on controlling hives and angioedema.

Is chronic spontaneous urticaria an autoimmune disease?

Chronic spontaneous urticaria can be driven by autoimmune mechanisms, but it is not accurate to say that every person with CSU has one confirmed autoimmune disease mechanism.

CSU is a mast cell-driven disease. Wheals and angioedema occur when mast cells in the skin become activated and release histamine and other inflammatory mediators.\[2\]

Researchers now recognise two important autoimmune pathways.

What is type I autoimmune CSU?

Type I autoimmune CSU, sometimes called autoallergic CSU, involves IgE antibodies that recognise substances produced by the person's own body.

Instead of IgE responding to an external allergen such as pollen, the antibody may recognise an internal antigen. Examples studied in CSU include thyroid peroxidase and IL-24. This can contribute to mast-cell activation.

What is type IIb autoimmune CSU?

Type IIb autoimmune CSU involves autoantibodies that can directly activate mast cells or basophils, including antibodies directed against IgE or its high-affinity receptor, FcεRI.

When strict research criteria are used — combining an autologous serum skin test, testing for relevant IgG autoantibodies and a basophil activation or histamine-release test — fewer than 10% of patients fulfil all criteria for type IIb autoimmune CSU.

Other patients may show some autoimmune features without meeting this strict definition. And in some cases, the mechanism remains unknown.

That is why the most accurate answer to "Is CSU autoimmune?" is: Autoimmunity is an important cause or mechanism in CSU, but it cannot currently be demonstrated in every patient.

Why can the autoimmune explanation feel important to patients?

The autoimmune explanation can help patients understand why years of searching for an external allergy may not have produced an answer.

This was one of the clearest themes in mama health's detailed conversations with Italian patients about autoimmunity and thyroid disease.\[1\]

Many patients reached an allergologist, dermatologist or immunologist after trying to identify foods, detergents, cosmetics, environmental allergens, or other possible external triggers — mama health's guide to CSU vs. allergy covers this search in more depth. Some had undergone several allergy tests without finding a consistent explanation.

For these patients, hearing that CSU could be driven by processes inside the immune system rather than by an unidentified food or environmental allergy could feel validating.\[1\] It gave them a different way to understand why eliminating more and more foods had not solved the problem.

However, patient narratives also showed inconsistent communication. Some specialists explicitly explained autoimmune CSU and its relationship with thyroid autoimmunity. Others told patients there was no meaningful connection. Patients were then left trying to reconcile apparently contradictory explanations themselves.\[1\]

Part of that disagreement comes from an important distinction: an association between CSU and autoimmunity is well supported. Identifying the exact autoimmune mechanism in an individual patient is much harder.

Is CSU the same as an allergy?

No. CSU is not usually caused by a conventional external allergy.

In a typical IgE-mediated allergy, symptoms repeatedly follow exposure to a specific allergen such as a particular food, medication or insect venom. CSU behaves differently — hives and angioedema appear spontaneously for more than six weeks, without one consistent external trigger explaining the episodes.\[2\]

That does not mean foods, medicines, heat, infections or stress can never worsen symptoms. They can act as aggravating factors in some people. It means that repeatedly searching for a single hidden allergen does not usually explain the underlying disease.

This distinction was important in what patients told mama health. People often described spending months or years believing there must be an allergy that had simply not yet been discovered.\[1\] For some, understanding CSU as a mast-cell-driven condition with possible autoimmune mechanisms finally made sense of why that search had been unsuccessful.

Do negative allergy tests prove that CSU is autoimmune?

No. Negative allergy tests do not prove an autoimmune cause.

A negative skin-prick test or allergen-specific IgE test can show that the test did not identify sensitisation to the allergens examined. It cannot establish type I or type IIb autoimmune CSU.

This distinction matters because the investigations answer different questions. Allergy testing asks: is there evidence that a particular external allergen is involved? Autoimmune-related assessment asks: are there features suggesting that internal immune mechanisms may be contributing to CSU?

The 2026 international guideline recommends limited rather than extensive routine investigations. Further allergy testing or autoimmune investigation should be guided by the patient's history, examination and initial results.

Negative allergy investigations therefore do not mean that testing was pointless. They may help clinicians move away from an unsupported allergy explanation. But they are not, by themselves, a diagnosis of autoimmune CSU.

What is the connection between CSU and thyroid disease?

People with chronic urticaria have higher rates of thyroid autoimmunity than people without chronic urticaria.

Thyroid autoimmunity occurs when the immune system produces antibodies directed at components of the thyroid gland. Common examples include anti-thyroid peroxidase antibodies (anti-TPO) and anti-thyroglobulin antibodies (anti-Tg). Hashimoto's thyroiditis is the autoimmune thyroid condition most commonly discussed in relation to CSU.

A 2022 meta-analysis included more than 14,000 people with chronic urticaria and 12,000 controls. People with chronic urticaria had more than a fivefold higher likelihood of anti-TPO positivity than controls.

A separate systematic review found that most large CSU studies reported thyroid autoantibodies in at least 10% of patients, although prevalence varied considerably between studies.

The relationship is therefore real. But having CSU does not mean that a person necessarily has Hashimoto's disease, hypothyroidism or another thyroid disorder.

How common are thyroid conditions among the patients mama health has spoken with?

A recorded thyroid condition appeared in a small minority of the Italian CSU patients mama health has talked with — hypothyroidism came up somewhat more often than thyroiditis specifically, including autoimmune forms such as Hashimoto's thyroiditis.\[1\]

Atopic conditions came up more frequently — allergies, food allergies, asthma, atopic dermatitis or eczema appeared in roughly one in six patients.\[1\] Comorbidities could overlap, so one patient could appear in more than one category, and a substantial share of patients had no comorbidity recorded at all.\[1\]

These patterns describe what patients reported or what was captured in their conversations with mama health. They should not be interpreted as results from systematic laboratory screening.

Why does this figure look lower than published research?

mama health's patient data and published thyroid-autoimmunity estimates measure different things.

mama health's figure describes recorded thyroid conditions in patient conversations. Many research studies instead take blood from every participant and actively look for anti-TPO or other thyroid autoantibodies, including in people who have never been diagnosed with thyroid disease.

A person can have thyroid autoantibodies while having normal thyroid hormone levels, having no thyroid symptoms, and not carrying a thyroid diagnosis. This helps explain why research based on systematic antibody screening often reports higher figures than patient-conversation data.

A large systematic review found elevated anti-thyroid antibodies in at least 10% of CSU patients in many studies, with rates varying widely depending on the population and methods used.

mama health's figure therefore should not be read as evidence against a thyroid-CSU association. It's better understood this way: thyroid disease was explicitly present in the recorded patient conversation for a small share of people, while undiagnosed or unrecorded thyroid autoimmunity may not have been captured at all.

Which thyroid tests may be considered in someone with CSU?

Anti-TPO and total IgE may be included in the specialist assessment of CSU, while additional thyroid testing depends on clinical context.

The 2026 international guideline recommends basic investigations including a differential blood count and CRP and/or ESR. For patients in specialist care, it states that total IgE and IgG anti-TPO may also be assessed.

Depending on the patient's history or initial findings, clinicians may also investigate thyroid disease using tests such as TSH, free T4, sometimes free T3, anti-TPO antibodies, and anti-thyroglobulin antibodies. These were also the tests patients most frequently recalled in mama health's conversations.\[1\]

The guideline does not recommend a large, indiscriminate laboratory search for every possible autoimmune condition in every person with CSU. Testing should be guided by the clinical history and findings.

A patient could therefore ask: "Would checking my thyroid function or thyroid antibodies add useful information in my case?"

What does a positive anti-TPO test mean if you have CSU?

A positive anti-TPO result indicates thyroid autoimmunity, but it does not prove that the thyroid antibodies themselves are causing the hives.

Anti-TPO antibodies are substantially more common among people with chronic urticaria than controls. They are also associated with some autoimmune CSU patterns — for example, type IIb autoimmune CSU is more often associated with elevated IgG anti-TPO, low total IgE, low basophil counts, and low eosinophil counts.

However, the 2026 guideline cautions that the ability of anti-TPO and total IgE to identify a particular CSU endotype remains limited. There are not yet sufficiently validated cut-offs to classify an individual patient with certainty.

A positive anti-TPO result therefore provides context, not a complete explanation.

Does a normal anti-TPO test mean your CSU is not autoimmune?

No. Normal thyroid antibodies do not rule out every autoimmune mechanism of CSU.

Anti-TPO is associated particularly strongly with some type IIb autoimmune CSU patterns, but it is not a definitive diagnostic test for autoimmune CSU. Type I autoimmune CSU involves IgE autoantibodies against different autoantigens. Type IIb disease involves functional autoantibodies against IgE or FcεRI. And some patients may have overlapping mechanisms.

This is another reason why "autoimmune CSU" cannot currently be confirmed or excluded using one routine blood test.

What are ASST and basophil activation tests?

The autologous serum skin test and basophil activation tests are specialist tests that can provide additional information about autoreactivity or autoimmune CSU.

What is the autologous serum skin test?

The autologous serum skin test (ASST) involves injecting a small amount of a patient's own serum into the skin and observing whether a wheal develops. A positive result indicates serum autoreactivity. However, a positive ASST alone does not prove type IIb autoimmune CSU.

What is a basophil activation test?

A basophil activation test (BAT) examines whether factors in a patient's blood activate basophils.

Strict research definitions of type IIb autoimmune CSU generally require several findings together: a positive ASST, relevant IgG autoantibodies, and a positive basophil activation or basophil histamine-release test.

The 2026 guideline notes that basophil activation testing can provide additional information but is not routinely performed for every CSU patient.

Should everyone with CSU have an ANA test?

No. ANA testing is not recommended as a universal routine test for every person with CSU.

ANA, or antinuclear antibody testing, can be useful when a patient's history or examination raises concern about a systemic autoimmune condition. However, CSU guidelines favour a focused diagnostic workup rather than screening every patient for every autoimmune disease.

This matters because positive autoimmune markers can occur without proving that someone has a specific systemic autoimmune disorder. Patients with symptoms that suggest another condition — for example persistent joint symptoms, unusual systemic symptoms or other clinical findings — may need additional investigation based on their healthcare professional's assessment.

Does treating hypothyroidism make chronic urticaria go away?

Treating hypothyroidism is important, but it does not reliably make CSU disappear.

This question was one of the most persistent themes in mama health's conversations with patients about autoimmunity and thyroid disease.\[1\] Patients with Hashimoto's disease or hypothyroidism often hoped that getting TSH and thyroid hormone levels into the normal range would finally stop their hives. Many reported that this did not happen.

Some patients described reaching normal thyroid hormone levels on levothyroxine — including specific Italian brand names such as Eutirox and Tiche — while their CSU flares continued regardless.\[1\]

Published evidence is also mixed. A 2026 systematic review and meta-analysis found improvement in chronic urticaria symptoms after levothyroxine in before-and-after analyses. However, levothyroxine was not superior to placebo or standard care in comparative analyses, and the authors concluded that evidence for a specific benefit on urticaria remains conflicting. An earlier systematic review likewise found inconsistent results and did not support prescribing thyroid hormone solely to treat CSU in people with normal thyroid function.

The practical message is therefore: a thyroid condition should be treated appropriately for the thyroid condition. CSU still needs its own assessment and treatment plan.

Should levothyroxine be used to treat CSU if thyroid hormone levels are normal?

Current evidence does not support routinely using levothyroxine solely as a CSU treatment in people with normal thyroid function.

Small studies have reported improvement in some patients with thyroid autoantibodies, but the evidence is inconsistent and controlled data have not established a reliable benefit. Levothyroxine is primarily used to replace thyroid hormone when clinically indicated.

A positive thyroid antibody result therefore does not automatically mean that thyroid hormone treatment is needed. The decision depends on thyroid function, symptoms and endocrine assessment.

Does autoimmune CSU change the usual treatment pathway?

Usually, autoimmune features provide additional information but do not replace the standard stepwise CSU treatment pathway.

The current international guideline recommends treatment according to disease control. Second-generation H1-antihistamines remain first-line treatment. If standard doses do not provide adequate control, the dose of one second-generation antihistamine may be increased up to fourfold under medical supervision. Higher-than-licensed dosing is off-label.\[2\]

For disease that remains uncontrolled, additional treatments can be considered according to the current CSU treatment algorithm.

Importantly, finding anti-TPO antibodies does not mean that antihistamines suddenly become irrelevant. Autoimmune mechanisms ultimately contribute to mast-cell activation, and antihistamines block one of the major mediators released by those cells. They help control symptoms even though they do not remove the underlying autoimmune tendency.

Does autoimmune CSU respond differently to omalizumab?

Some autoimmune CSU patterns are associated with different average responses to omalizumab, but biomarkers cannot yet reliably predict one patient's response.

Omalizumab targets IgE and is an established add-on treatment for CSU that remains uncontrolled despite antihistamines. Research suggests that people with strict type IIb autoimmune CSU can have lower total IgE, higher anti-TPO, higher disease activity, and a slower or less complete response to omalizumab on average.

However, these are group-level associations. The 2026 international guideline specifically notes that the predictive accuracy of available biomarkers remains limited.

A patient should therefore not interpret positive thyroid antibodies as evidence that omalizumab will or will not work.

Why can an autoimmune explanation change how patients feel about biologic treatment?

Understanding CSU as an immune-mediated condition can make targeted treatment feel easier to understand, even though it does not determine whether an individual should receive a biologic.

This appeared repeatedly in mama health's patient conversations.\[1\] Before the autoimmune explanation, some patients described antihistamines as simply "covering up" unexplained symptoms. Once a specialist explained mast-cell activation, IgE and autoimmune mechanisms, treatments such as omalizumab could feel more logically connected to what was happening in their body. That understanding sometimes reduced resistance to discussing advanced treatment.\[1\]

However, the reason for starting a biologic should still be based on disease control, previous treatment and appropriate clinical assessment, rather than on the label "autoimmune" alone.

Does having Hashimoto's disease mean your CSU will be worse?

Not necessarily, although thyroid autoimmunity is associated with particular CSU characteristics in some studies.

Autoimmune thyroid disease is one of the best-established autoimmune comorbidities of CSU. Type IIb autoimmune CSU is also associated with a higher prevalence of other autoimmune diseases and tends, on average, to show higher disease activity.

But these associations do not allow clinicians to predict one person's disease course from a Hashimoto's diagnosis. Some people with thyroid autoimmunity have mild CSU. Some people with severe CSU have completely normal thyroid testing. The thyroid diagnosis is one part of the clinical picture rather than a prognosis by itself.

Does autoimmune CSU mean it can be cured?

No. Identifying an autoimmune mechanism does not currently provide a guaranteed cure for CSU.

This was another source of confusion in what patients told mama health. For some, finally hearing the word autoimmune felt like discovering the missing cause. They understandably expected that identifying the mechanism might reveal a way to eliminate it.\[1\]

Current knowledge does not work that way. Autoimmune endotyping helps researchers and clinicians understand how CSU may be occurring. It does not currently provide a treatment that permanently switches off the autoimmune process in every patient.

CSU can nevertheless enter remission over time, including after years of disease. Treatment is focused on achieving complete disease control while the condition remains active.

Why are food elimination diets often disappointing in autoimmune CSU?

Elimination diets are often disappointing because conventional food allergy is rarely the underlying cause of CSU.

Patients told mama health they'd frequently spent years experimenting with food restriction before receiving an autoimmune or immune-mediated explanation.\[1\] Some removed dairy, gluten, histamine-rich foods, additives, alcohol, or multiple food groups at once — mama health's guide to CSU diet and nutrition covers which food changes actually have some evidence behind them. The absence of a response could feel like another failed attempt to understand the disease.

This does not mean food can never aggravate symptoms in an individual. It means that removing increasing numbers of foods is unlikely to solve CSU when there is no consistent evidence that a particular food is involved.

A focused discussion with a healthcare professional can help decide whether allergy testing or a time-limited dietary assessment is justified rather than maintaining unnecessary restrictions indefinitely.

What should you ask your doctor about autoimmunity and thyroid disease with CSU?

Useful questions focus on which tests are relevant, what the results would mean and whether they would actually change care. Based on mama health's patient conversations and current clinical guidance, patients could consider asking:

1. Do you think autoimmune mechanisms may be contributing to my CSU?
2. What is the difference between autoimmune CSU and having another autoimmune disease such as Hashimoto's?
3. Would checking anti-TPO and total IgE be useful in my case?
4. Should my thyroid function, including TSH and free T4, be checked based on my history?
5. If anti-TPO is positive but my thyroid function is normal, what does that mean?
6. Do I need follow-up for thyroid autoimmunity separately from my CSU?
7. Would ANA or other autoimmune tests add useful information, or are they unnecessary based on my symptoms?
8. Would a basophil activation test or another specialist test actually change how my CSU is managed?
9. If my allergy tests are negative, what does that tell us — and what does it not tell us?
10. If my thyroid levels become normal on treatment but my hives continue, what is the CSU plan?
11. Do my test results tell us anything reliable about how I might respond to omalizumab?
12. Does having thyroid autoimmunity change how often I should be reviewed?

These questions can help structure a medical conversation. They are not instructions to request a particular laboratory test or treatment.

What should you remember about CSU, autoimmunity, and thyroid disease?

The relationship between CSU and autoimmunity is real, but it is more nuanced than saying "CSU is a thyroid autoimmune disease."

CSU is a mast-cell-driven condition. In some people, type I or type IIb autoimmune mechanisms help explain why those cells become activated. In others, the underlying mechanism cannot yet be clearly classified.

Thyroid autoimmunity is one of the strongest autoimmune associations seen with chronic urticaria. People with chronic urticaria are substantially more likely to have anti-TPO antibodies than controls.

In mama health's conversations with Italian patients, a diagnosed or reported thyroid condition came up in a small minority — a figure that's lower than antibody-screening studies because it measures something different: thyroid disease captured in the patient's own account, rather than systematic testing of every participant.\[1\]

The detailed conversations behind that pattern also show why explaining this distinction matters. Patients often spent years searching for foods or environmental allergies before someone explained that the disease might be driven internally. For many, that was validating.

But the autoimmune explanation has limits. A negative allergy test does not prove autoimmune CSU. A positive anti-TPO result does not prove thyroid antibodies are causing the hives. Normalising thyroid hormone levels does not reliably stop CSU. And identifying an autoimmune pattern does not currently guarantee a cure.

The useful outcome of testing is therefore not simply to collect more abnormal results. It is to understand which information is relevant, what it means, and whether it changes the conversation about care.

###

Disclaimer: This content is informational and not medical advice. mama health offers information and support and does not replace a doctor.